Health Services and Systems Research, Duke-NUS Medical School, Singapore.
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Diabetes Metab J. 2019 Aug;43(4):474-486. doi: 10.4093/dmj.2018.0171. Epub 2019 Mar 20.
Fetuin-A is a hepatokine that involved in the pathogenesis of insulin resistance. Previous epidemiological studies have found a positive association between blood fetuin-A and type 2 diabetes mellitus (T2DM) risk among Caucasians and African Americans. We aimed to investigate the prospective relationship between fetuin-A and T2DM in an Asian population for the first time.
A nested case-control study was established within a prospective cohort of Chinese living in Singapore. At blood collection (1999 to 2004), all participants were free of diagnosed T2DM and aged 50 to 79 years. At subsequent follow-up (2006 to 2010), 558 people reported to have T2DM and were classified as incident cases, and 558 controls were randomly chosen from the participants who did not develop T2DM to match with cases on age, sex, dialect group, and date of blood collection. Plasma fetuin-A levels were measured retrospectively in cases and controls using samples collected at baseline. Conditional logistic regression models were used to compute the odds ratio (OR) and 95% confidence interval (CI). Restricted cubic spline analysis was used to examine a potential non-linear association between fetuin-A levels and T2DM risk.
Compared with those in the lowest fetuin-A quintile, participants in the highest quintile had a two-fold increased risk of developing T2DM (OR, 2.06; 95% CI, 1.21 to 3.51). A non-linear association was observed ( nonlinearity=0.005), where the association between fetuin-A levels and T2DM risk plateaued at plasma concentrations around 830 μg/mL.
There is a positive association between plasma fetuin-A levels and risk of developing T2DM in this Chinese population.
胎球蛋白-A 是一种肝分泌物,参与胰岛素抵抗的发病机制。以前的流行病学研究发现,白种人和非裔美国人的血液胎球蛋白-A 与 2 型糖尿病(T2DM)风险之间存在正相关。我们旨在首次在亚洲人群中研究胎球蛋白-A 与 T2DM 之间的前瞻性关系。
在新加坡居住的亚洲人前瞻性队列中建立了嵌套病例对照研究。在采血时(1999 年至 2004 年),所有参与者均未被诊断出患有 T2DM,年龄在 50 至 79 岁之间。在随后的随访期间(2006 年至 2010 年),有 558 人报告患有 T2DM,并被归类为发病病例,从未发生 T2DM 的参与者中随机选择 558 名对照与病例按年龄、性别、方言组和采血日期相匹配。使用基线时采集的样本,通过回顾性检测病例和对照者的血浆胎球蛋白-A 水平。使用条件逻辑回归模型计算比值比(OR)和 95%置信区间(CI)。限制性三次样条分析用于检查胎球蛋白-A 水平与 T2DM 风险之间的潜在非线性关联。
与最低胎球蛋白-A 五分位组相比,最高五分位组的参与者发生 T2DM 的风险增加了两倍(OR,2.06;95%CI,1.21 至 3.51)。观察到非线性关联(非线性=0.005),胎球蛋白-A 水平与 T2DM 风险之间的关联在血浆浓度约为 830μg/mL 时趋于平稳。
在该中国人群中,血浆胎球蛋白-A 水平与发生 T2DM 的风险之间存在正相关。